Neuroaxonal Injury in Acute HIV Infection and Following Immediate Antiretroviral Therapy
Open Access
- 19 November 2025
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (4) , e913-e922
Abstract
Background: This study evaluates the degree of neuroaxonal injury during acute HIV infection (AHI) in neuroasymptomatic individuals and the neuroprotective effect of antiretroviral therapy (ART) initiated during AHI, by measuring neurofilament light (NFL), glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells 2 (sTREM2) in cerebrospinal fluid (CSF) samples collected during pre-ART AHI and at post-ART visits up to 5 years. Methods: RV254 cohort participants (99% male, median age 27 years) were enrolled during Fiebig I-V AHI. A subset completed optional lumbar punctures during pre-ART AHI (week 0, n = 136) and/or at post-ART visits with HIV suppression (weeks 24, 48, 96; and 240, n = 201). RV254 CSF NFL measurements were compared to those of 44 people without HIV (PWoH), both adjusted to a sampling age of 30, and to age-based upper normal limits (UNL). Results: RV254 participants demonstrated higher CSF NFL than PWoH at pre-ART AHI (P < .001), and post-ART weeks 24 (P < .001) and 48 or later (week 48+, P = .003). CSF NFL was elevated (ie, >UNL) in 15%, 8%, and 7% of RV254 participants at weeks 0, 24, and 48 + respectively, versus 2% among PWoH. During AHI, elevated CSF NFL was associated with later Fiebig stages (III-V) (P = .034), higher CSF HIV RNA (P = .012) and a smaller difference between HIV RNA in the plasma and CSF (P = .002). Additionally, CSF NFL increased with GFAP and sTREM2 during pre-ART AHI and post-ART visits (P < .050). Conclusions: CNS injury may occur during AHI. Additionally, early ART alone is likely insufficient to provide complete neuroprotection.Keywords
Funding Information
- Advancement of Military Medicine, Inc.
- National Institutes of Health (AAI21058-001-01000)
- Norges Idrettshøgskole (R01MH095613, R01MH106466, R01NS084911, R01MH130197)
This publication has 49 references indexed in Scilit:
- Chemsex and rising substance use linked to sexually transmitted infections among men who have sex with men living with HIV in Bangkok, ThailandIJID Regions, 2024
- Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trialJournal of Virus Eradication, 2024
- HIV-Proteins-Associated CNS Neurotoxicity, Their Mediators, and Alternative TreatmentsCellular and Molecular Neurobiology, 2021
- Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016JAMA Network Open, 2020
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in NeurologyJAMA Neurology, 2019
- Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive ImpairmentJAMA Neurology, 2019
- Depression and Anxiety are Common in Acute HIV Infection and Associate with Plasma Immune ActivationAIDS and Behavior, 2017
- Screening Yield of HIV Antigen/Antibody Combination and Pooled HIV RNA Testing for Acute HIV Infection in a High-Prevalence PopulationJAMA, 2016
- Rapid screening for psychologic distress in men with prostate carcinomaCancer, 1998
- A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adultsJournal of Neuroscience Methods, 1994